| Serial Number | 97754154 |
| Word Mark | GONIOSOL |
| Filing Date | Friday, January 13, 2023 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Thursday, May 2, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations for the treatment and prevention of ocular diseases and disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 3, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | OPUS Life Sciences, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Portland, OR 97239 |
| Event Date | Event Description |
| Friday, February 3, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 10, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, January 17, 2023 | NEW APPLICATION ENTERED |
| Wednesday, October 11, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, October 11, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, October 11, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, April 26, 2024 | ASSIGNED TO LIE |
| Friday, April 26, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, April 26, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 2, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, May 2, 2024 | FINAL REFUSAL WRITTEN |
| Thursday, May 2, 2024 | FINAL REFUSAL E-MAILED |
| Thursday, December 7, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |